Northern Trust
CGON icon

Northern Trust’s CG Oncology CGON Stock Holding History

Northern Trust’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.2M Buy
677,912
+158,243
+30% +$10.3M 0.01% 1212
2026
Q1 		$35.2M Buy
519,669
+37,729
+8% +$2.14M ﹤0.01% 1337
2025
Q4 		$20M Sell
481,940
-9,399
-2% -$389K ﹤0.01% 1646
2025
Q3 		$19.8M Buy
491,339
+23,237
+5% +$676K ﹤0.01% 1693
2025
Q2 		$12.2M Sell
468,102
-3,662
-0.8% -$88.2K ﹤0.01% 1948
2025
Q1 		$11.6M Buy
471,764
+37,904
+9% +$1.07M ﹤0.01% 1953
2024
Q4 		$12.4M Buy
433,860
+52,419
+14% +$1.79M ﹤0.01% 1997
2024
Q3 		$14.4M Buy
381,441
+197,461
+107% +$6.92M ﹤0.01% 1840
2024
Q2 		$5.81M Buy
183,980
+976
+0.5% +$33.8K ﹤0.01% 2311
2024
Q1 		$8.03M Buy
+183,004
New +$7.47M ﹤0.01% 2184

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust's CGON Position: Q2 2026 in Review

Northern Trust increased its CG Oncology (CGON) stake by 30% in Q2 2026, buying an estimated $10.3M and bringing the position to 677,912 shares worth $48.2M. The position accounts for 0.01% of the portfolio, ranked #1212.

Northern Trust first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Northern Trust held 677,912 shares of CG Oncology worth $48.2M as of Q2 2026.
  • Northern Trust bought 158,243 CG Oncology shares in Q2 2026, an estimated $10.3M.
  • CG Oncology made up 0.01% of Northern Trust's portfolio in Q2 2026, its #1212 holding.
  • Northern Trust first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.